Related Experiment Video
Updated: May 10, 2026
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Simple versus complex truncus arteriosus: neutralization of risk but with increased resource utilization
John A Hawkins1, Aditya K Kaza, Phillip T Burch
1Division of Pediatric Cardiothoracic Surgery, Primary Children's Medical Center, Salt Lake City, UT, USA.
World Journal for Pediatric & Congenital Heart Surgery
|June 28, 2013
Summary
This study found that complex truncus arteriosus (TA) repair in infants does not increase mortality or reintervention risk compared to simple TA. However, complex cases require longer hospital stays and intensive care.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Medical Outcomes Research
Background:
- Truncus arteriosus (TA) is a rare congenital heart defect.
- Outcomes for simple versus complex TA forms require ongoing evaluation.
Purpose of the Study:
- To compare outcomes of simple and complex truncus arteriosus (TA) repair.
- To assess mortality, reintervention rates, and resource utilization in current TA treatment eras.
Main Methods:
- Retrospective analysis of 42 infants undergoing primary TA repair (1999-2008).
- Categorization into simple TA (no associated anomalies) and complex TA (with risk factors).
- Comparison of early/late mortality, reintervention, survival, and resource use.
Main Results:
- No significant difference in early or late mortality between simple and complex TA.
- Reintervention rates and actuarial survival were similar for both groups.
- Complex TA cases showed significantly longer hospital stays and ICU intubation times.
Conclusions:
- Complex truncus arteriosus (TA) does not carry a higher mortality or reintervention risk than simple TA.
- While survival and reintervention are comparable, complex TA necessitates greater resource utilization.
- Age and weight were not predictors of adverse outcomes in multivariable analysis.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...